Citation: | MA Ying, PENG Zhi-lan, CHEN Xin, et al. The Regulation Mechanism of MASPIN Expression in Ovarian Carcinoma[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 15-20. |
[1] |
Zou Z, Anisowicz A, Hendrix MJC, et al.Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells. Science,1994;263(5146):526-529.
|
[2] |
Pemberton PA, Tipton AR,Pavloff N,et al. Maspin is an intracellular serpin that partitions into secretory esicles and is present at the cell surface. J Histochem Cytochem,1997;45(12):1697-1706.
|
[3] |
Song SY,Lee SK,Kim DH,et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig Dis Sci,2002;47(8):1831-1835.
|
[4] |
Maass N, Teffner M, Rosel F, et al. Decline in the expression of the serpin proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol,2001;195(3):321-326.
|
[5] |
Sood AK, Fletcher MS, Gruman LM,et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res,2002;8(9):2924-2932.
|
[6] |
Zou Z, Gao C, Nagaich AK,et al. P53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem,2000;275(9):6051-6054.
|
[7] |
Futscher BW, Oshiro MM, Wozniak RJ, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet,2002;31(2):175-179.
|
[8] |
Kim S, Han J, Kim J,et al.Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res,2004;64(1):6900-6905.
|
[10] |
Zhang M, Magit D,Sager R. Expression of maspin in prostate cells is regulated by a positive Ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci U S A,1997;94(11):5673-5678.
|
[11] |
Sato N, Fukushima N, Matsubayashi H, et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene,2004;23(8):1531-1538.
|
[12] |
Oshiro MM,Watts GS,Wozniak RJ,et al.Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene,2003;22(23):3624-3634.
|
[13] |
Umekita Y, Ohi Y, Souda M, et al.Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Diagn Pathol,2011;6:36.
|
[14] |
Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell,1998;2(3):305-316.
|
[15] |
Dohn M,Zhang S,Chen X.p63alpha and dehaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.Oncogene,2001;20(25):3193-3205.
|
[16] |
Naylor LH. Reporter gene technology: the futhre looks bright. Biochem Pharmacol,1999;58(5):749-757.
|
[17] |
Erchuck A, Robert C. P53 based gene therapy of ovarian cancer magic bullet. J Gynecol Oncol,1995;59(2):169-171.
|
[18] |
De Laurenzi V,Melino G. Evolution of funotions within the p53/p63/p73 family.Ann N Y Acad Sci,2000;926(12):90-100.
|